Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

Related Articles by Review for PubMed (Select 19817787)

1.

Genetic and biochemical pathways of beta-cell failure in type 2 diabetes.

Talchai C, Lin HV, Kitamura T, Accili D.

Diabetes Obes Metab. 2009 Nov;11 Suppl 4:38-45. doi: 10.1111/j.1463-1326.2009.01115.x. Review.

PMID:
19817787
2.
3.

Pancreatic beta-cell growth and survival--a role in obesity-linked type 2 diabetes?

Lingohr MK, Buettner R, Rhodes CJ.

Trends Mol Med. 2002 Aug;8(8):375-84. Review.

PMID:
12127723
4.

Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.

Lupi R, Del Prato S.

Diabetes Metab. 2008 Feb;34 Suppl 2:S56-64. doi: 10.1016/S1262-3636(08)73396-2. Review.

PMID:
18640587
5.

Role of autophagy in β-cell function and mass.

Hur KY, Jung HS, Lee MS.

Diabetes Obes Metab. 2010 Oct;12 Suppl 2:20-6. doi: 10.1111/j.1463-1326.2010.01278.x. Review.

PMID:
21029296
6.

Animal models of type 2 diabetes with reduced pancreatic beta-cell mass.

Masiello P.

Int J Biochem Cell Biol. 2006;38(5-6):873-93. Epub 2005 Oct 4. Review.

PMID:
16253543
7.
8.

Tissue-specificity of insulin action and resistance.

Benito M.

Arch Physiol Biochem. 2011 Jul;117(3):96-104. doi: 10.3109/13813455.2011.563748. Epub 2011 Apr 20. Review.

PMID:
21506723
9.

Protection of pancreatic beta-cells: is it feasible?

Bonora E.

Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):74-83. Review.

PMID:
18096375
10.

Thiazolidinediones and the preservation of beta-cell function, cellular proliferation and apoptosis.

Decker M, Hofflich H, Elias AN.

Diabetes Obes Metab. 2008 Aug;10(8):617-25. Epub 2007 Jul 21. Review.

PMID:
17645549
11.

Regulating insulin signaling and beta-cell function through IRS proteins.

White MF.

Can J Physiol Pharmacol. 2006 Jul;84(7):725-37. Review.

PMID:
16998536
12.

Abnormalities in insulin secretion in type 2 diabetes mellitus.

Guillausseau PJ, Meas T, Virally M, Laloi-Michelin M, Médeau V, Kevorkian JP.

Diabetes Metab. 2008 Feb;34 Suppl 2:S43-8. doi: 10.1016/S1262-3636(08)73394-9. Review.

PMID:
18640585
14.

Functional pancreatic beta-cell mass: involvement in type 2 diabetes and therapeutic intervention.

Karaca M, Magnan C, Kargar C.

Diabetes Metab. 2009 Apr;35(2):77-84. doi: 10.1016/j.diabet.2008.09.007. Epub 2009 Feb 28. Review.

15.

Glucotoxicity and beta-cell failure in type 2 diabetes mellitus.

Kaiser N, Leibowitz G, Nesher R.

J Pediatr Endocrinol Metab. 2003 Jan;16(1):5-22. Review.

PMID:
12585335
16.

Glucose metabolism: key endogenous regulator of β-cell replication and survival.

Dadon D, Tornovsky-Babaey S, Furth-Lavi J, Ben-Zvi D, Ziv O, Schyr-Ben-Haroush R, Stolovich-Rain M, Hija A, Porat S, Granot Z, Weinberg-Corem N, Dor Y, Glaser B.

Diabetes Obes Metab. 2012 Oct;14 Suppl 3:101-8. doi: 10.1111/j.1463-1326.2012.01646.x. Review.

PMID:
22928570
17.

Pancreatic beta-cell loss and preservation in type 2 diabetes.

Buchanan TA.

Clin Ther. 2003;25 Suppl B:B32-46. Review.

PMID:
14553865
18.

The pancreatic beta-cell in human Type 2 diabetes.

Marchetti P, Del Prato S, Lupi R, Del Guerra S.

Nutr Metab Cardiovasc Dis. 2006 Mar;16 Suppl 1:S3-6. Epub 2006 Feb 9. Review.

PMID:
16530127
20.

Mouse models of insulin resistance.

Hribal ML, Oriente F, Accili D.

Am J Physiol Endocrinol Metab. 2002 May;282(5):E977-81. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk